Search
for
Sort by
Research 571–600 of 1000+
- 5α-reductase Inhibitors: Finasteride and Dutasteride in Feminising Therapy
- Pharmacokinetic-pharmacodynamic modeling approach for dose prediction of the optimal long-acting injectable formulation of finasteride
- The Postnatal Offspring of Finasteride-Treated Male Rats Shows Hyperglycaemia, Elevated Hepatic Glycogen Storage and Altered GLUT2, IR, and AR Expression in the Liver
- Nanoemulgel for Efficient Topical Delivery of Finasteride Against Androgenic Alopecia
- Finasteride and Suicide: A Postmarketing Case Series
- Viable terminal scalp hair follicles constitute a necessary and sufficient biological end‐organ that conditions clinical efficacy of finasteride in males with male pattern hair loss without implying reversal of miniaturized follicles
- Development of finasteride polymer microspheres for systemic application in androgenic alopecia
- Determination of finasteride and its metabolite in urine by dispersive liquid–liquid microextraction combined with field-enhanced sample stacking and sweeping
- Optimisation of microstructured biodegradable finasteride formulation for depot parenteral application
- Whisker hair (acquired progressive kinking of the hair): An indication for finasteride 1 mg?
- Finasteride administration potentiates the disruption of prepulse inhibition induced by forced swim stress
- [Transurethral seminal vesiculoscopy combined with finasteride for recurrent hematospermia].
- Finasteride associated melasma in a Caucasian male.
- Efficacy and safety of 3% minoxidil versus combined 3% minoxidil / 0.1% finasteride in male pattern hair loss: a randomized, double-blind, comparative study.
- Finasteride in the treatment of female pattern (androgenic) alopecia: a case report and review of the literature.
- Bioequivalence Study of Finasteride
- Pharmacokinetics of 2 Novel Formulations of Modified-Release Oral Testosterone Alone and With Finasteride in Normal Men With Experimental Hypogonadism
- Effect of finasteride on ovulation induction in nonresponder (hyperandrogenic) polycystic ovary syndrome (PCOS) women
- Aphalangia possibly linked to unintended use of finasteride during early pregnancy
- Effect of Solvent on Stereoselectivity in Pd/C (Type 39K)-Catalyzed Hydrogenation of Methyl 3-Oxo-4-aza-5-androstene-17-carboxylate, A Key Intermediate for Finasteride and Dutasteride
- Follow-Up of 1 mg Finasteride Treatment of Male Pattern Baldness-Difference between Clinical Trials and Private Office Follow-Up: Influences on Prescribing Habits Evaluated
- Pharmacokinetic Interaction between Finasteride and Terazosin, but not Finasteride and Doxazosin
- Assessment of the Pharmacokinetic -Pharmacodynamic Interaction Between Terazosin and Finasteride
- Effect of MK-386, a novel inhibitor of type 1 5 alpha-reductase, alone and in combination with finasteride, on serum dihydrotestosterone concentrations in men.
- Additive in vivo growth-inhibitory effects of flutamide and finasteride on androgen-sensitive Shionogi 115 carcinoma
- Analyzing finasteride data
- Finasteride blocks progesterone synthesis in MA-10 Leydig tumor cells.
- Ongoing Concerns Regarding Finasteride for the Treatment of Male-Pattern Androgenetic Alopecia
- Enhanced Follicular Delivery of Finasteride to Human Scalp Skin Using Heat and Chemical Penetration Enhancers
- Placebo‐controlled dose‐effect studies with topical minoxidil 2% or 5% in male‐patterned hair loss treated with oral finasteride employing an analytical and exhaustive study protocol